Results 11 to 20 of about 3,768,680 (342)

Ligands binding diffusively to protein target act as inhibitors of protein-protein interactions. [PDF]

open access: yesPLoS Computational Biology
Nuclear localization signal (NLS) sequence from capsid protein of Venezuelan equine encephalitis virus (VEEV) binds to importin-α transport protein and clogs nuclear import. Prevention of viral NLS binding to importin-α may represent a viable therapeutic
William Jeffries   +12 more
doaj   +2 more sources

AI-first structural identification of pathogenic protein target interfaces. [PDF]

open access: yesPLoS Computational Biology
The risk of pandemics is increasing as global population growth and interconnectedness accelerate. Understanding the structural basis of protein-protein interactions between pathogens and hosts is critical for elucidating pathogenic mechanisms and ...
Mihkel Saluri   +2 more
doaj   +2 more sources

Multiplexed in-gel microfluidic immunoassays: characterizing protein target loss during reprobing of benzophenone-modified hydrogels. [PDF]

open access: yesSci Rep, 2019
From whole tissues to single-cell lysate, heterogeneous immunoassays are widely utilized for analysis of protein targets in complex biospecimens. Recently, benzophenone-functionalized hydrogel scaffolds have been used to immobilize target protein for ...
Gopal A, Herr AE.
europepmc   +4 more sources

Optimal TELSAM-Target Protein Linker Character is Target Protein-Dependent [PDF]

open access: yesStructural Dynamics
The fusion of the sterile alpha motif domain of the human translocation ETS leukemia protein (TELSAM) to a protein of interest has been shown to significantly enhance crystallization propensity and improve diffraction quality.
Maria Jose P Romo   +19 more
doaj   +3 more sources

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

open access: yesGenomics, Proteomics & Bioinformatics, 2022
After decades of development, protein and peptide drugs have now grown into a major drug class in the marketplace. Target identification and validation are crucial for the discovery of protein and peptide drugs, and bioinformatics prediction of targets ...
Zhongyang Liu   +10 more
doaj   +3 more sources

Deubiquitinase-targeting chimeras for targeted protein stabilization [PDF]

open access: yesNature Chemical Biology, 2022
Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we present deubiquitinase-targeting chimeras (DUBTACs), heterobifunctional small molecules consisting of a deubiquitinase recruiter linked to a protein-targeting ligand, to ...
Nathaniel J. Henning   +23 more
openaire   +4 more sources

Chemodivergent assembly of ortho-functionalized phenols with tunable selectivity via rhodium(III)-catalyzed and solvent-controlled C-H activation

open access: yesCommunications Chemistry, 2021
Ortho functionalisation of phenols can be achieved using N-phenoxy amide directing groups. Here a method for chemodivergent C-H alkenylation, alkylation, carboetherification, or [3 + 2] annulation is presented, with product selectivity determined by the ...
Haiman Zhang   +6 more
doaj   +1 more source

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus

open access: yesFrontiers in Endocrinology, 2021
Type 2 diabetes Mellitus (T2DM) prevalence has significantly increased worldwide in recent years due to population age, obesity, and modern sedentary lifestyles. The projections estimate that 439 million people will be diabetic in 2030.
Karina Ramírez-Alarcón   +14 more
doaj   +1 more source

Amphiphilic Aminated Derivatives of [60]Fullerene as Potent Inhibitors of Tumor Growth and Metastasis

open access: yesAdvanced Science, 2022
Malignant proliferation and metastasis are the hallmarks of cancer cells. Aminated [70]fullerene exhibits notable antineoplastic effects, promoting it a candidate for multi‐targeted cancer drugs.
Jiawei Huo   +16 more
doaj   +1 more source

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants

open access: yesFrontiers in Immunology, 2021
Since the coronavirus disease outbreak in 2019, several antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Antibody therapeutics are effective in neutralizing the virus and reducing
Sua Lee   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy